Abstract
Challenges can arise in the management of chronically-transfused patients. Solve it!
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, et al. Guidelines on the use of therapeutic apheresis in clinical practice—evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue. J Clin Apher. 2019;34:303.
Hayes MM, Vedamurthy A, George G, Dweik R, Klings ES, Machado RF, et al. Pulmonary hypertension in sickle cell disease. Ann Am Thorac Soc. 2014;11(9):1488–9.
Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. Prevention of a first stroke by transfusion in children with abnormal results of transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5–11.
Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005;353:2769–78.
Randolph TR. Hemoglobinopathies (structural defects in hemoglobin). In: Keohane EM, Otto CN, Walenga JM, editors. Rodak’s hematology. Clinical principles and applications. 6th ed. Amsterdam: Elsevier; 2020. p. 406–8.
Biller E, Zhao Y, Berg M, Boggio L, Capocelli KE, Fang DC, et al. Red blood cell exchange in patients with sickle cell disease-indications and management: a review and consensus report by the therapeutic apheresis subsection of the AABB. Transfusion. 2018;58(8):1965–72.
Hoffbrand AV, Taher A, Cappellini MD. How I treat transfusional iron overload. Blood. 2012;120(18):3657–69.
Stussi G, Buser A, Holbro A. Red blood cells: exchange, transfuse, or deplete. Transfus Med Hemother. 2019;46(6):407–16.
Ziemba Y, Xu C, Fomani KM, Nandi V, Yuan T, Rehmani S, et al. Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion. Transfusion. 2021;61(2):526–36.
EXJADE® prescribing information. East Hanover, NJ: Novartis Pharmaceuticals Corp. April 2011.
Desferal® prescribing information. East Hanover, NJ: Novartis Pharmaceuticals Corp. July 2019.
HYDREA® prescribing information. Princeton, NJ: Bristol-Myers Squibb Co. March 2016.
Agrawal RK, Patel RK, Shah V, Nainiwal L, Trivedi B. Hydroxyurea in sickle cell disease: drug review. Indian J Hematol Blood Transfus. 2014;30(2):91–6.
SIKLOS® prescribing information. Bryn Mawr, PA: Medunik USA. December 2017.
Ware RE, Helms RW, SWiTCH Investigators. Stroke with transfusions changing to hydroxyurea (SWiTCH). Blood. 2012;119(17):3925–32.
Ware RE, Davis BR, Schultz WH, Brown RC, Aygun B, Sarnaik S, et al. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial Doppler flow velocities in children with sickle cell anaemia-TCD with transfusions changing to hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet. 2016;387(10,019):661–70.
ENDARI™ prescribing information. Torrence, CA: Emmaus Medical. July 2017.
OXBRYTA® prescribing information. South San Francisco, CA: Global Blood Therapeutics. January 2021.
Rutherford-Parker NJ, Campbell ST, Colby JM, Shajani-Yi Z. Voxelotor treatment interferes with quantitative and qualitative hemoglobin variant analysis in multiple sickle cell disease genotypes. Am J Clin Pathol. 2020;154(5):627–34.
ADAKVEO® prescribing information. East Hanover, NJ: Novartis Pharmaceuticals Corp. July 2021.
Ribeil J-A, Bey-Abina SH, Payen E, Magnani A, Semeraro M, Magrin E, et al. Gene therapy in a patient with sickle cell disease. N Engl J Med. 2017;376:848–55.
King A, Shenoy S. Evidence-based focused review of the status of hematopoietic stem cell transplantation as treatment of sickle cell disease and thalassemia. Blood. 2014;123(20):3089–94.
Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012;1823(9):1434–43.
Further Reading
Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005;353:2769–78.
Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. Prevention of a first stroke by transfusion in children with abnormal results of transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5–11.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Friedman, M.T., West, K.A., Bizargity, P., Annen, K., Gur, H.D., Hilbert, T. (2023). Heavy Metal. In: Immunohematology, Transfusion Medicine, Hemostasis, and Cellular Therapy. Springer, Cham. https://doi.org/10.1007/978-3-031-14638-1_74
Download citation
DOI: https://doi.org/10.1007/978-3-031-14638-1_74
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-14637-4
Online ISBN: 978-3-031-14638-1
eBook Packages: MedicineMedicine (R0)